CJ CheilJedang said it expects improved conditions in its bio business from the fourth quarter, and that its ADM joint venture should support amino-acid manufacturing and sales. The company also reported lower performance-ingredient operating profit quarter over quarter as methionine spot prices fell.
Lower methionine spot prices weigh on ingredient producers and may signal softer near-term pricing for feed buyers. The article gives no indication of a supply disruption or demand surge that would reverse that pressure.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.